Skip to Main Content

The Sackler family members who own Purdue Pharma have agreed to pay up to $6 billion to settle a hotly contested bankruptcy plan, which will allow state governments and tens of thousands of people to be compensated for the company’s role in the opioid crisis.

The deal comes after years of litigation over the marketing of the OxyContin painkiller, which was a cash cow for the drugmaker and became a poster child for the nationwide epidemic. The company was blamed for helping to trigger these events by downplaying the risk of addiction while improperly encouraging physicians to write prescriptions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment